APP and Alzheimer disease: The targets related to AD and sulforaphane clustered around three biological processes (Fig. 5A), including “positive regulation of nitric oxide biosynthetic process”, “negative regulation of apoptotic signaling pathway”, and “amyloid precursor protein catabolic process”.